GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Inventories, Finished Goods

SillaJen (XKRX:215600) Inventories, Finished Goods : ₩2,142 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Inventories, Finished Goods?

SillaJen's quarterly finished goods increased from Mar. 2024 (₩1,645 Mil) to Jun. 2024 (₩2,169 Mil) but then declined from Jun. 2024 (₩2,169 Mil) to Sep. 2024 (₩2,142 Mil).

SillaJen's annual finished goods increased from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩1,063 Mil) and increased from Dec. 2022 (₩1,063 Mil) to Dec. 2023 (₩1,444 Mil).


SillaJen Inventories, Finished Goods Historical Data

The historical data trend for SillaJen's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SillaJen Inventories, Finished Goods Chart

SillaJen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,062.74 1,444.26

SillaJen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,115.59 1,444.26 1,644.65 2,168.85 2,142.36

SillaJen Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


SillaJen Business Description

Industry
Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines